Skip to main content
Professional Technical IVT

RANO criteria

Also written as: RANO — Response Assessment in Neuro-Oncology

Standardized response assessment guidelines for neuro-oncology trials, essential for consistent editorial treatment of efficacy data.

Full Definition

Response Assessment in Neuro-Oncology (RANO) criteria provide standardized guidelines for evaluating treatment response in brain tumor clinical trials. These criteria address the unique challenges of assessing brain tumors, including the effects of corticosteroids, pseudoprogression, and non-enhancing tumor components. RANO criteria incorporate clinical assessment alongside imaging findings and have specific adaptations for different tumor types. Editors must understand these criteria when reviewing efficacy data and ensure consistent terminology when describing response categories.

Usage

Usage note: Always specify which version of RANO criteria used; distinguish from iRANO (immunotherapy-specific) criteria when applicable.

In Context

  • "Tumor response was assessed using RANO criteria with independent radiological review." — Clinical trial methodology
  • "The patient achieved a partial response according to RANO criteria maintained for 8 months." — Clinical efficacy report

Also known as

Response Assessment in Neuro-Oncology criteria

Contrasted with

WHO criteria RECIST criteria

Don't confuse with

RECIST criteria MacDonald criteria iRANO criteria

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON